Page URL:

Parkinson's disease genes involved in mitochondrial recycling

16 August 2021
Appeared in BioNews 1108

Genes linked to hereditary Parkinson's disease have been found to play a role in recycling mitochondrial products to generate new mitochondria.

Researchers in California have found that Parkinson's disease-associated genes, PINK1 and Parkin, are crucial in the mitochondrial life cycle. Disruption of this pathway could contribute to neurodegenerative conditions, such as Parkinson's.

'This appears to be a new mitochondrial quality control, recycling system,' said co-first author of the research Dr Huihui Li, from Gladstone Institutes in San Francisco. 'We think we've uncovered a pathway of mitochondrial recycling—which is like salvaging valuable furniture in a house before demolishing it.'

Whilst much is known about mitochondrial recycling in other cell types, the process in neurons – the cells affected in neurodegenerative diseases – is less well understood. However, neurons are known to have very high energy demands and mitochondria are essential to energy supply. 

The research team used a novel approach to track neuronal mitochondria over time, by combining time-lapse imaging with powerful microscopy. They tracked individual mitochondria for almost a full day at a time. 

They found that Parkin proteins encircled damaged mitochondria to target them for a specific type of degradation known as mitophagy. Mitophagy involves the fusion of mitochondria with another part of the cell to form structures called mitolysosomes.

'Until now, nobody has known what happens next to these mitolysosomes… We were able to visualise these steps at a level that hasn't been done before in any cell type,' said senior author Professor Ken Nakamura.

It was previously thought that mitolysosomes were rapidly broken down into molecules for the cells to reuse. However, the research group found that mitolysosomes persisted in the cell for hours; often being engulfed by healthy mitochondria, or spontaneously bursting to release their contents. Without PINK1 or Parkin proteins this process was unable to occur.

'Our study advances our understanding of how these two key Parkinson's disease proteins degrade and recycle mitochondria' said Professor Nakamura. 'Our future studies will investigate how these pathways contribute to disease and how they can be targeted therapeutically.'

The study was published in the journal Science Advances

13 September 2021 - by Bethany Muller 
New research detailing how mitochondria maintain proper function could lead to improved treatments for conditions such as Alzheimer's and diabetes...
3 December 2018 - by Caroline Casey 
A gene therapy relieves Parkinson's disease symptoms by rewiring the brain circuits involved in movement...
4 November 2013 - by Dr Rachel Montgomery 
Eleven genetic variants linked to late-onset Alzheimer's disease have been found by the largest study on the genetics behind the condition to date...
25 March 2013 - by Helen Brooks 
An experimental approach to treating Parkinson's disease may need to be reconsidered following evidence suggesting that it may make patients worse...
26 January 2006 - by BioNews 
US researchers have found that many cases of Parkinson's disease (PD) in certain ethnic groups could be triggered by a single faulty gene. In two separate studies, the scientists discovered that some patients with an Ashkenazi Jewish or Arabic background have a mutated version of the LRRK2 gene. The findings...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.